Begin main content

Reports

We found 6271 result(s)

doravirine (Pifeltro )

Last Updated: December 19, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: doravirine
Indications: HIV-1

  • Brand Name: Pifeltro
  • Manufacturer: Merck Canada Inc.
  • Project Number: SR0582-000
  • Project Status: Active
  • Submission Type: New

benralizumab (Fasenra)

Last Updated: December 21, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: benralizumab
Indications: Asthma, severe eosinophilic

  • Brand Name: Fasenra
  • Manufacturer: AstraZeneca Canada Inc.
  • Project Number: SF0592-000
  • Project Status: Complete
  • Submission Type: RequestForAdvice

mepolizumab (Nucala)

Last Updated: December 21, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: mepolizumab
Indications: Asthma, severe eosinophilic

  • Brand Name: Nucala
  • Manufacturer: GlaxoSmithKline Inc.
  • Project Number: SF0593-000
  • Project Status: Complete
  • Submission Type: RequestForAdvice

tofacitinib (Xeljanz)

Last Updated: April 23, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: tofacitinib
Indications: Ulcerative colitis

  • Brand Name: Xeljanz
  • Manufacturer: Pfizer Canada Inc.
  • Project Number: SR0572-000
  • Project Status: Complete
  • Submission Type: NewIndication

reslizumab (Cinqair)

Last Updated: December 21, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: reslizumab
Indications: Asthma, eosinophilic

  • Brand Name: Cinqair
  • Manufacturer: TEVA Canada Innovation
  • Project Number: SF0591-000
  • Project Status: Complete
  • Submission Type: RequestForAdvice

cyclosporine (Verkazia)

Last Updated: April 24, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: cyclosporine
Indications: Severe vernal keratoconjunctivitis, pediatric (≥4 years)

  • Brand Name: Verkazia
  • Manufacturer: Santen Inc.
  • Project Number: SR0615-000
  • Project Status: Pending
  • Submission Type: New